DRUG · Mapped RxNorm record
Flutamide
Normalized identity: flutamideView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer
NCT00223665
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Leuprolide Acetate
Normalized identity: leuprolide acetateView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEffects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
FlutamideDRUG · verified · RxNorm: flutamide
Leuprolide AcetateDRUG · verified · RxNorm: leuprolide acetate
Sponsors & collaborators
University of Washingtonlead sponsor
Sanoficollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00223665 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.